Cargando…

Immunotherapy for penile cancer

Detalles Bibliográficos
Autores principales:	Buonerba, Carlo, Pagliuca, Martina, Vitrone, Francesca Maria, Ascione, Ilaria, Elefante, Ivana, Riccio, Vittorio, Romano, Francesca, De Placido, Sabino, Di Lorenzo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583688/ https://www.ncbi.nlm.nih.gov/pubmed/28883996 http://dx.doi.org/10.4155/fsoa-2017-0031

Ejemplares similares

The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

Complete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case Report
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial
por: Buonerba, Carlo, et al.
Publicado: (2018)

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study
por: Bosso, Davide, et al.
Publicado: (2017)

Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Buonerba, Carlo, et al.
Publicado: (2020)

Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
por: Buonerba, Carlo, et al.
Publicado: (2019)

Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2013)

Immune checkpoint inhibitors in penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2021)

High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial
por: Marinelli, Alfredo, et al.
Publicado: (2018)

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study
por: Buonerba, Carlo, et al.
Publicado: (2016)

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2015)

Second-line treatment for renal cell cancer
por: Di Lorenzo, G, et al.
Publicado: (2012)

Urethrocutaneous fistula following penile fracture
por: Scovell, Jason M., et al.
Publicado: (2014)

Toll-like receptors and COVID-19: a two-faced story with an exciting ending
por: Onofrio, Livia, et al.
Publicado: (2020)

Penile lichen sclerosus: An enigmatic and challenging disease
por: Grivas, Nikolaos
Publicado: (2015)

The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice
por: Celsa, Ciro, et al.
Publicado: (2023)

Immune landscape and immunotherapy for penile cancer
por: Tang, Yaxiong, et al.
Publicado: (2022)

Immunotherapy in cervical cancer: the advent of precision medicine
por: De Felice, Francesca, et al.
Publicado: (2020)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
por: De Martino, Mara, et al.
Publicado: (2021)

Does this patient have COVID-19? A practical guide for the internist
por: Bertolino, Lorenzo, et al.
Publicado: (2020)

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
por: Riccio, Gennaro, et al.
Publicado: (2016)

The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients
por: Germani, Marco Maria, et al.
Publicado: (2022)

Preparing Pharmacists for Collaborative/Integrated Health Settings
por: Ascione, Frank J.
Publicado: (2019)

Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells
por: Brito, Haissa O., et al.
Publicado: (2021)

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020)

Magnetic resonance imaging of penile paraffinoma: case report
por: Cormio, Luigi, et al.
Publicado: (2014)

An unusual delayed complication of paraffin self-injection for penile girth augmentation
por: De Siati, Mario, et al.
Publicado: (2013)

Digging into the HLA pockets: A new association with acute leukaemias
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Effective combinatorial immunotherapy for penile squamous cell carcinoma
por: Huang, Tianhe, et al.
Publicado: (2020)

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era
por: Hui, Gavin, et al.
Publicado: (2019)

Predictive Response to Immunotherapy Score: A Useful Tool for Identifying Eligible Patients for Allergen Immunotherapy
por: Mormile, Ilaria, et al.
Publicado: (2022)

Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?
por: Fonsatti, Ester, et al.
Publicado: (2004)

Low-dose irradiation for reversing immunotherapy resistance: how to translate?
por: Ochoa-de-Olza, Maria, et al.
Publicado: (2022)

Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?
por: Palmieri, Giuseppe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jna7mq094402qvtnqmheabhr53